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Abstract : We showed previously that 8-wk consumption of a diet containing palatinose
(P, a slowly-absorbed sucrose analogue) and oleic acid (O) ameliorates but a diet contain-
ing sucrose (S) and linoleic acid (L) aggravates metabolic abnormalities in Zucker fatty
(fa/fa) rats. In this study, we aimed to identify early changes inmetabolism in rats induced
by certain combinations of carbohydrates and fatty acids. Specifically, male Zucker
fatty rats were fed an isocaloric diet containing various combinations of carbohydrates
(P ;S) and fatty acids (O ;L). After 4 wk, no significant differences in bodyweight, visceral
fat mass, plasma parameters (glucose, insulin, lipids, and adipokines), hepatic adiposity
and gene expression, and adipose inflammation were observed between dietary groups.
In contrast, pancreatic islets of palatinose-fed (PO and PL) rats were smaller and less
fibrotic than sucrose-fed (SO and SL) rats. The abnormal-cell distribution and sporadic
staining of active caspase-3 common to islets of linoleic-acid-fed rats were not observed
in oleic-acid-fed (PO and SO) rats. Accordingly, progressive-cell loss was seen in SL rats,
but not in PO rats. These findings suggest that pancreatic islets may be initial sites that
translate the effects of different combinations of dietary carbohydrates and fats intometa-
bolic changes. J. Med. Invest. 55 : 183-195, August, 2008
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INTRODUCTION
Visceral obesity is the most prevalent manifesta-
tion of ametabolic syndrome that associates closely
with insulin resistance, type 2 diabetes, and cardio-
vascular disease. Although complex interactions
between many genetic and environmental factors
contribute to the development of obesity, diet is
considered the single most important etiological
factor. Human and animal studies have shown that
excess intake of simple sugars and fats is the prin-
cipal lifestyle-related cause of both obesity and obe-
sity-related metabolic disorders that contribute to
the metabolic syndrome (1, 2).
It has been suggested that specific types of die-
tary carbohydrates and fats influence the risk of de-
veloping diet-induced metabolic disorders. Rapidly
digestible (i.e., high glycemic) saccharides such
as sucrose and fructose that increase blood glu-
cose levels, particularly in the postprandial period,
have a consequent effect on insulin and triglyceride
levels and have been suggested to increase risks
of obesity and insulin resistance (3). In contrast,
slowly digestible (i.e., low glycemic) carbohydrates
such as oligosaccharides and resistant starches have
been shown to prevent postprandial hyperglycemia
and hyperinsulinemia (1). Ingestion of palatinose
[isomaltulose ; 6-0-(α-0-glucopyranosyl)-D- fruc-
tofuranose], a slowly digestible sucrose analog com-
posed of α-1,6 -linked glucose and fructose, has
been reported to improve diabetic symptoms (4).
Epidemiological studies of ingested fats indicate
that while insulin resistance and obesity-related dis-
eases worsen with ingestion of saturated fatty ac-
ids, these conditions improve with ingestion of poly-
unsaturated fatty acids (PUFA) and monounsatu-
rated fatty acids (MUFA) (2). Linoleic and oleic
acids are two of the major fatty acids found in die-
tary fat and plasma triglycerides. Linoleic acid 18 :
2(n -6) has been implicated in upregulation of in-
flammatory responses via its conversion to arachi-
donic acid 20 : 4(n - 6), which is a precursor to in-
flammatory eicosanoids such as prostaglandins
and hydroperoxyeicosatetraenoic acids (HPETEs)
(5). On the other hand, dietary MUFA [particu-
larly oleic acid 18 : 1(n -9)] has been linked to a low
prevalence of atherosclerosis, beneficial changes in
lipoprotein distribution, and improved pancreatic
β-cell secretory function following disruption by
chronic hyperglycemia and hyperlipidemia (6 -9).
One significant limitation to the interpretation of
the aforementioned studies is that none focus on
nutrient-nutrient interactions. Diets consist of food
mixtures containing complex combinations of in-
teractive and synergistic nutrients, and these com-
binations and interactions need to be taken into ac-
count. We reported previously that a liquid balanced
formula (MHN-01/Inslow) containing palatinose
and oleic acid suppressed postprandial hyperglyce-
mia and hyperinsulinemia, reduced visceral fat
accumulation, and improved insulin sensitivity in
healthy men and Sprague-Dawley rats (10, 11). We
also have shown that various symptoms of obesity
in Zucker fatty (fa/fa) rats were attenuated by long-
term (8 wk) consumption of a diet containing pala-
tinose and oleic acid, but aggravated by a diet con-
taining sucrose and linoleic acid (12). These results
suggest that dietary carbohydrates and fats could
influence glucose and lipid metabolism concertedly
in vivo . Because the differential effects of these com-
binations of nutrients were not fully investigated in
the foregoing study, our aim in this study was to
examine the effects of combinations of dietary car-
bohydrates (palatinose and sucrose) and fats (oleic
acid and linoleic acid) on the metabolic profile in
obesity. Our specific aim was to identify the organ
in Zucker fatty rats responsible for the initial meta-
bolic alterations induced by experimental diets, a
key discovery toward development of a strategic die-
tary approach for preventing obesity-related meta-
bolic disorders.
MATERIALS AND METHODS
Animals
Twenty male, 11 wk old Zucker fatty (fa/fa) rats
(Charles River, Kanagawa, Japan) weighing 450-
470 g were caged individually in a climate-controlled
room (temperature, 231; humidity 70 to 75% ;
specific pathogen-free) with a 12 h light/dark cycle.
Prior to the initiation of our study, the rats were
allowed free access to standard rodent powder diet
(MF ; Oriental Yeast, Tokyo, Japan) and water.
Diets
The experimental diets were prepared fresh
weekly, sealed in air-tight plastic bags, and stored
at 4to avoid rancidity. The composition of each
diet is listed in Table 1. Safflower oil served as the
linoleic acid-rich oil (L) ; a mixture of high oleic sun-
flower oil and perilla oil served as the oleic acid-rich
oil (O). The final composition of the diet (g/kg) was
212.8 of total milk protein and casein, 353.2 of pa-
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latinose or sucrose, 157.5 of dextrin, 63.8 of indi-
gestible dextrin, 72.3 of vitamin and mineral mixture,
and 140.4 of test oil.
Experimental design
Rats were randomly assigned to one of 4 dietary
groups, each containing 4 rats, that were fed either
a diet rich in sucrose and linoleic acid (SL), sucrose
and oleic acid (SO), palatinose and linoleic acid (PL),
or palatinose and oleic acid (PO). To eliminate dif-
ferences in energy states due to altered palatability
among these diets, PO-based pair - feeding was
performed as previously described (12). Food intake
was monitored and the food itself was replaced
daily ; body weights were recorded weekly through-
out the feeding period.
After four weeks, the rats were deprived food for
24 h and then sacrificed for blood and tissue collec-
tion. Blood samples collected from the rats’ tail
veins were used to determine plasma glucose and
insulin levels. The rats were then anesthetized with
diethyl ether and blood was withdrawn from the
jugular vein for use in all other measurements. To
avoid the influences of intestinal contents on these
measures (which in a preliminary feeding experi-
ment proved considerable after a 12 h-only fast),
blood composition determinations were made after
a 24 h fast. Rats were subsequently sacrificed for
harvest and weight measurement of liver, visceral
fat and pancreatic samples.
The Institutional Animal Care and Oversight Com-
mittee approved the experimental protocols of the
study, which were carried out according to the guide-
lines and principles for the care and use of animals
at the University of Tokushima.
Plasma glucose, insulin, lipid and adipocytokine
concentrations
Plasma glucose was determined using the glu-
cose dehydrogenase method and an Accu-Chek
Table 1. Composition of Experimental Diets1
Diet
SL SO PL PO
g/kg diet
Total milk protein and casein 2 212.8 212.8 212.8 212.8
Fat 3 140.0 140.0 140.0 140.0
Carbohydrate 510.7 510.7 510.7 510.7
Indigestible dextrin 63.8 63.8 63.8 63.8
Vitamin and mineral mixture 4 72.3 72.3 72.3 72.3
Fatty acid composition %
palmitic acid 16 : 0 7.3 6.7 7.3 6.7
stearic acid 18 : 0 2.6 4.2 2.6 4.2
oleic acid 18 : 1(n-9) 13.4 72.3 13.4 72.3
linoleic acid 18 : 2(n-6) 76.4 10.7 76.4 10.7
α-linolenic acid 18 : 3(n-3) 0.2 4.4 0.2 4.4
Other fatty acids - 1.7 - 1.7
Carbohydrate composition %
Palatinose 0.0 0.0 70.0 70.0
Sucrose 70.0 70.0 0.0 0.0
Dextrin 30.0 30.0 30.0 30.0
Total energy 5, kJ/g 17.8 17.8 17.8 17.8
1 All of the diets were identical except for the types of fats and carbohydrates : (SL) sucrose and linoleic acid diet ; (SO) sucrose
and oleic acid diet ; (PL) palatinose and linoleic acid diet ; (PO) palatinose and oleic acid diet.
2 Percentages of total milk protein and casein were 60 and 40, respectively.
3 The fat component of L or O was derived from safflower oil or high-oleic sunflower oil blended with perilla oil, respectively.
Percentages of high-oleic sunflower oil and perilla oil were 90 and 10, respectively.
4 The weights of vitamins and minerals (per kg of diet) were as follows. Vitamins supplied : 3.2 mg retinyl palmitate, 31.9 μg chole-
calciferol, 340.4 mg α-tocopherol, 42.6 μg menadione and phylloquinone, 255.3 mg thiamin HCl, 21.3 mg riboflavin, 89.4 mg nicoti-
namide, 12.8 mg pyridoxine HCl, 42.6 mg calcium pantothenate, 1.7 g L-ascorbic acid, 825.5 mg choline, 2.1 mg folic acid, 38.3 μg
cyanocobalamin and 12.3 μg biotin. Minerals supplied : 3.0 g sodium, 3.4 g calcium, 42.6 mg iron, 3.4 g phosphorus, 1.1 g magnesium,
3.4 g potassium, 2.1 mg copper, 0.4 mg manganese, 42.6 mg zinc, 2.6 g chloride, 148.9 μg selenium, 127.7 μg chromium, 119.1 μg
iodine and 123.4 μg molybdenum.
5 Percentages of energy as fat, carbohydrate and protein were 29.7, 50.3 and 20.0, respectively.
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blood glucose meter (Roche Diagnostics, Tokyo,
Japan). Plasma insulin was measured by ELISA
(Morinaga, Yokohama, Japan). Plasma triglyceride,
cholesterol, and free fatty acid (FFA) levels were
determined using Triglyceride-E-, Cholesterol-E-,
and NEFA-C- tests (Wako Pure Chemical Industries,
Osaka, Japan), respectively. Commercial ELISAs
were used to measure plasma adiponectin (Otsuka
Seiyaku, Tokyo, Japan) and TNFα concentrations
(Biosource International, Camarillo, CA, USA).
Hepatic triglyceride concentration
Hepatic lipids were extracted as described pre-
viously (13). Triglyceride levels were measured in
lipid extracts resuspended in methanol using a com-
mercial kit (Triglyceride-E-kit, Wako Pure Chemi-
cal Industries).
RNA preparation and quantitative RT-PCR
To assess diet-induced changes in gene expres-
sion, steady-state mRNA levels from genes involved
in glucose and lipid homeostasis were measured
in PCR analyses of reverse-transcribed total RNA
templates (RT-PCR). Total RNA was isolated from
snap-frozen liver samples using the commercially
available acid-phenol reagent Trizol (Invitrogen,
Carlsbad, CA, USA). First-strand cDNAs were syn-
thesized from 5 μg of total RNA using an oligo-dT
primer and M-MLV reverse transcriptase (Invitro-
gen) at 42for 60 min and 95for 5 min. Real-
time PCR using gene-specific primers and SYBR
green dye (SYBR Premix Ex TaqTM ; TAKARA
BIO, Shiga, Japan) were performed in a LightCy-
cler (Roche Diagnostics) according to the manufac-
turer’s instructions. The following primers were
used : PEPCK [GenBank : AH007109] (forward ,
5’-AGACAAATCCGAACGCCATT-3’ ; reverse, 5’-
CATCCTGTGGTCTCCACTCT-3 ’) : glucokinase
[GenBank : J04218] (forward , 5’-GTGAGGCACG-
AAGACCTAGA-3’ ; reverse, 5’-CTGTGTCGTTCA-
CCATTGCC-3’) : LXRα [GenBank : NM_031627]
(forward , 5’-CCTCAAGATGCAGGAGACCA-3’ ;
reverse, 5’ -TAGGCTCGGATGACTCCAAC-3’) :
SREBP-1 [GenBank : AF286470] (forward , 5’ -
GGAGCCATGGATTGCACATTT-3’ ; reverse, 5’-
TCCTTCCGAAGGTCTCTCCTC-3 ’ ) : SREBP-2
[GenBank : XM_216989] (forward , 5’-ACTGTCAC-
TGGAGTCAGGTT-3’ ; reverse, 5’-GACCAACAGCT-
TCACGAAGA-3’) : PPARα [GenBank : M88529]
(forward , 5’-TGTATGAAGCCATCTTCACG-3’ ; re-
verse, 5’-GGCATTGAACTTCATAGCGA-3’) :TNFα
[GenBank : NM_031144] (forward , 5’-ATGGATC-
TCAAAGACAACCA-3’ ; reverse, 5’-TCCTGGTAT-
GAAATGGCAAA-3’). For each sample, the expres-
sion levels of individual genes were normalized rela-
tive to constitutively expressed β-actin [GenBank :
NM_031144] (forward , 5’-GTCCCAGTATGCCT-
CTGGTCGTAC-3’ ; reverse, 5’-CCACGCTCGGT-
CAGGATCTTCATG-3’) in the same sample, and
then expressed as a ratio relative to the same gene’s
expression level in the SL group (arbitrarily set at 1).
Histological and immunohistochemical analyses
Liver, epididymal adipose tissue and pancreatic
samples were fixed in 4% buffered paraformalde-
hyde, embedded in paraffin, sectioned, deparaffinized
in xylene, stained with Mayer’s hematoxylin and
eosin (Wako Pure Chemical Industries) and exam-
ined by light microscopy. Masson’s trichrome stain
(14) was performed to assess islet fibrosis.
For immunohistochemical staining, slides were
microwaved for 5 min in 10 mmol/L sodium citrate
(pH 6.0) to retrieve antigen. After blocking in 5%
BSA for 2 h at room temperature, slides were in-
cubated with primary antibodies as follows : over-
night at 4 for rabbit polyclonal IgG anti-F4/80
(Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and mouse monoclonal IgG anti-insulin (Nichirei
Bioscience, Tokyo, Japan) ; for 30 min at room tem-
perature for rabbit polyclonal IgG anti-glucagon
(Thermo Scientific, CA, USA) ; for 5 h at 4 for
rabbit polyclonal IgG anti-active/cleaved caspase-
3 (Imgenex, CA, USA). Slides were subsequently
washed in PBS and incubated with peroxidase-
conjugated goat anti-rabbit or anti-mouse IgG (En-
Vision+ System-HRP ; DakoCytomation, Carpinte-
ria, CA, USA) for 1 h at room temperature. The im-
munoreactivity of each sample was visualized with
DAB (Nakalai Tesk, Kyoto, Japan) and samples
were counterstained with Mayer’s hematoxylin
(Wako Pure Chemical Industries).
Cell areas of adipocyte, pancreatic islet, insulin-
immunoreactive β-cell areas and intraislet fibrosis
areas were measured with masking using Image-
Pro Plus 6.0 Software (Media-Cybernetics, Silver
Spring, MD, USA). The frequency of crown-like
structure (CLS) formation was calculated from
micrographs as follows : [number of F4/80 positive
CLS/number of total adipocytes] x100.
Statistical analysis
Results are expressed as meanSEM. Statisti-
cally significant effects of dietary carbohydrate and
fat were determined using two-way ANOVA fol-
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lowed by the Tukey-Kramer post hoc test in cases
of significant interaction. To test for significant dif-
ferences in morphological measures of pancreatic
islets and epididymal fat cells, we applied the non-
parametric Kruskal-Wallis test followed by Scheffe’s
post hoc test. A P value of 0.05 was considered
significant. Statistical tests were performed using
StatView 5.0 (SAS, Cary, NC, USA) and Excel-
Toukei 2006 (SSRI, Tokyo, Japan).
RESULTS
Body and organ weights and blood chemistry
During the initial 4 wk feeding period, energy
intake was similar in all groups (Table 2). Although
the four groups of rats did not differ significantly
in body weight or visceral fat accumulation, epidi-
dymal fat pads of the PL group were significantly
heavier than the PO group. Relative liver weights
were not affected by the treatments. The diet treat-
ment also did not result in significant changes in
plasma concentrations of glucose, insulin, triglyc-
eride, total cholesterol, FFA, adiponectin and TNFα
(Table 3).
Liver
At both a gross and histological level, the appear-
ance of liver fattiness was similar in all groups
(Fig. 1A), and was matched by an absence of sig-
nificant differences in hepatic triglyceride levels
(P =0.737, two-way ANOVA) (Fig. 1B).
Expression of PEPCK (gluconeogenesis), glu-
cokinase (glycolysis), SREBP-1, SREBP-2, LXRα
(lipogenic transcription factors) and PPARα (a tran-
scription factor in the nuclear receptor superfamily
regulating fatty acid β-oxidation), which are impor-
tant for hepatic regulation of blood glucose and lip-
ids, was measured by RT-PCR from liver total RNA.
As predicted by the constancy of plasma glucose
and lipid concentrations, expression levels of these
genes also were not affected by changes in diet
(Fig. 1C). Although a previous report demonstrated
Table 2. Body and organ weights and energy intake of Zucker fatty rats fed combinations of carbohydrates (C) and fats (F) for
four weeks1
Diet 2-Way ANOVA
C F CF
Variable SL SO PL PO P-values
Body weight, g 537.67.4 539.915.8 536.87.6 551.312.0 0.432 0.720 0.873
Visceral fat, g/kg BW 115.42.5 111.63.8 112.34.3 104.33.4 0.189 0.136 0.604
Mesenteric fat 36.11.6 34.41.8 33.92.6 32.00.4 0.224 0.339 0.948
Epididymal fat 31.00.2 a,b 31.60.8 a,b 34.91.3 a 29.71.5 b 0.319 0.070 0.025
Retroperitoneal fat 48.41.1 45.61.7 43.51.6 42.72.7 0.058 0.341 0.600
Liver, g/kg BW 29.13.4 25.22.2 32.91.1 28.81.6 0.121 0.098 0.990
Energy intake, KJ/d 395.910.5 388.415.3 401.412.0 402.813.1 0.455 0.816 0.736
1 Values are meansSEM, n=4. Within a row, means marked with unlike superscripts are significantly different, P0.05.
Table 3. Plasma concentrations of glucose, insulin, lipids and adipokines in Zucker fatty rats fed combinations of carbohydrates
(C) and fats (F) for four weeks1
Diet 2-Way ANOVA
C F CF
Variable SL SO PL PO P-values
Glucose, mmol/L 5.71.0 4.80.2 5.20.4 5.004 0.796 0.405 0.578
Insulin, pmol/L 3010330 2500110 3260340 2980200 0.187 0.156 0.659
Triglyceride, mmol/L 2.170.14 2.000.20 2.470.13 2.630.50 0.085 0.941 0.506
Total cholesterol,
mmol/L 3.410.38 3.520.34 4.280.10 3.670.32 0.176 0.507 0.296
Free fatty acid, mmol/L 0.890.96 0.960.08 0.940.12 0.910.06 0.974 0.852 0.577
Adiponectin, mg/L 7.360.43 7.570.49 7.330.24 7.490.37 0.924 0.635 0.955
TNFα, ng/L 39.799.23 26.392.19 45.8914.61 30.264.35 0.874 0.120 0.900
1 Values are meansSEM, n=4.
The Journal of Medical Investigation Vol. 55 August 2008 187
that Zucker fatty rats fed the SL and PL diets for
8 weeks showed increased levels of pro- inflamma-
tory gene mRNAs in the liver (12), we observed
no significant differences in hepatic TNFα gene
expression or plasma TNFα concentrations between
these groups in the current study (Table 3).
Adipose tissue
No significant differences in mean adipocyte area
were detected between groups (P =0.096, Kruskal-
Wallis test), indicating that the 4 wk-diet treatment
did not affect adipocyte size (Fig. 2A).
White adipose tissue (WAT) inflammation, which
is attributed primarily to infiltrating pro-inflammatory
macrophages, is an early event in the development
of obesity-related metabolic disorders (15, 16). Lo-
calization of macrophages to CLS around individual
adipocytes occurs during WAT inflammation, and
increases in density with increased obesity (17).
Three measures indicative of macrophage density
were assessed from adipose tissue samples of each
diet group : the intensity of F4/80-immunostaining
(i.e., macrophages) (Fig. 2B), steady-state levels
of TNFα, cyclooxygenase-2 and Emr1 (F4/80)
mRNAs (data not shown), and the formation of F
4/80-positive CLS in epididymal WAT (P =0.384,
two-way ANOVA) (Fig. 2B). We observed no sig-
nificant differences in any of these parameters be-
tween diet groups. These results indicate that four
weeks of ingesting these experimental diets had
no discernable effect on development of WAT in-
flammation in Zucker fatty rats.
A B
C
Fig. 1. Hepatic steatosis and gene expression in Zucker fatty rats fed combinations of carbohydrates and fats for four weeks
(A) HE-stained paraffin-embedded liver sections (4 μm-thick, original magnification,200) and gross appearance of livers (scale
bar, 1 cm) from SL, SO, PL, or PO rats. (B) Triglyceride content of liver. (C) Quantitative real-time PCR analysis of mRNA levels
from hepatic genes relevant to glucose and lipid metabolism and inflammation (normalized to β-actin). Normalized expression levels
from the SL group were set arbitrarily at 1. Values are meansSEM, n=4 per group. P values, by 2-way ANOVA.
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PANCREAS
Morphology
In contrast, we observed striking differences in
islet morphology in HE-stained pancreatic sections
derived from rats in the four diet groups (Fig. 3).
After 4 wk of treatment, islets from sucrose-fed
(SL and SO) rats were large and irregular-shaped,
with some expansion into adjacent exocrine tissue
suggestive of islet hypertrophy. Overall, these ab-
normal, irregularly shaped islets were most abun-
dant in SL rats. The islets from palatinose-fed (PL
and PO) rats were smaller than sucrose-fed rats ;
section from PO rats showed a large number of
normal, round or oval islets, whereas some irregu-
larity in shape was apparent in islets from PL rats
(Fig. 3A). Mean islet area in the sucrose-fed groups
was significantly larger than in the palatinose-fed
groups (Fig. 3B) ; these results were consistent
with the features observed in the Zucker fatty rats
fed same diets for 8 wk (12). Thus, islet hypertro-
phy associated with consumption of dietary sucrose,
as opposed to palatinose.
When samples were stained for insulin, intense
brown, insulin-positive staining of islets was seen
most frequently in PO rats relative to the other
three groups. In contrast, SL rats maintained islets
that showed an attenuated and variable pattern
of staining suggestive of progressive β-cell loss
(Fig. 3A). Consistent with staining, the mean pro-
A B
Fig. 2. Adipocyte morphology and WAT macrophage localization in Zucker fatty rats fed combinations of carbohydrates and fats
for four weeks
(A) HE-stained paraffin-embedded sections (7 μm-thick, magnification bar=100 μm) and adipocyte area of epididymal WAT from
SL, SO, PL, or PO rats. At least 300 adipocytes from each rat were analyzed. (B) Anti-F4/80-immunostained paraffin-embedded
sections (7 μm-thick, magnification bar=50 μm) and frequencies of F4/80-positive crown-like structure (CLS) formation of epididymal
WAT from SL, SO, PL, or PO rats. Values are meansSEM, n=4 per group.
A B
Fig. 3. Islet size, morphological β-cell mass and islet architecture in Zucker fatty rats fed combinations of carbohydrates and fats
for four weeks
(A) Paraffin-embedded serial sections of pancreas from SL, SO, PL, or PO rats were stained with HE (upper row), or anti-insulin
(middle row) or anti-glucagon antibodies (lower row). Hematoxylin counterstained. 4 μm-thick ; magnification bar=100 μm. (B)
Proportion of insulin-imunoreactive area to total islet area in pancreas. Twenty randomly chosen islets from each rat were analyzed.
Values are meansSEM, n=4 per group. Means with superscripts without a common letter differ, P0.001.
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portion of β-cell area to islet area in the PO group
was significantly higher than others, whereas β-cell
area was lowest in the SL group (Fig 3B).
Glucagon staining revealed abnormal islet-cell
architecture in linoleic-acid-fed (PL and SL) rats ;
these rats had glucagon-positve α-cells distributed
throughout islet that showed a disrupted mantle-
like boundary structure. In contrast, the islet archi-
tecture of oleic-acid-fed (PO and SO) rats was nearly
normal, with α-cells distributed only at the periph-
ery of the islet. The peripheral mantle of α-cells
was less dense and more centrally localized in SO
rats compared to PO rats (Fig 3A).
Islet fibrosis
Using Masson’s trichrome stain (blue staining),
we assessed the degree of islet fibrosis (a common
feature of several rat models of diabetes with pro-
gressive β-cell loss) to investigate the effects of die-
tary factors on the altered morphology and loss of
β-cells (18, 19). Islet fibrosis was significantly more
aggravated in sucrose-fed rats than in palatinose-
fed rats (Fig. 4). Islets from rats fed the SL diet
were disrupted at their boundaries and showed the
greatest area of fibrosis, with some apparent in
exocrine tissue as well (Fig. 4).
Islet cell apoptosis
Apoptosis has been shown to be the primary
mechanism driving β-cell loss (20). Since pro-
apoptotic caspase-3 activity is indicated by the nu-
clear localization of cleaved (activated) caspase-3
(20), we used immunohistochemical detection of
activated caspase-3 in pancreatic islet to measure of
β-cell apoptosis. In linoleic-acid-fed rats, intense im-
munostaining of nuclei around islet boundaries indi-
cated increased β-cell apoptosis in these rats (Fig. 5).
Relative to SL and PL rats, activated caspase-3 was
detected sporadically in the islets of SO rats and
infrequently in the islets of PO rats.
DISCUSSION
To assess the beneficial or adverse effects of spe-
cific dietary factors on metabolic disorders in obe-
sity, we tested the effects of four diets that in-
cluded one of two types of carbohydrates (palati-
nose or sucrose) and fats (oleic acid or linoleic acid)
on Zucker fatty rats. Our findings demonstrate
clearly that particular combinations of carbohydrate
and fat vary with respect to their effects on me-
tabolism and obesity.
After four weeks, all of the rats fed any of the
four diets showed similar body and adipose tissue
Fig. 4. Islet fibrosis in Zucker fatty rats fed combinations of
carbohydrates and fats for four weeks
Masson’s trichrome staining (collagen shown in blue) of par-
affin-embedded pancreas sections from SL, SO, PL, or PO rats.
4 μm-thick, magnification bar=100 μm.
Fig. 5. Islet cell apoptosis in Zucker fatty rats fed combina-
tions of carbohydrates and fats for four weeks
Paraffin-embedded pancreas sections from SL, SO, PL, or PO
rats immunostained for pro-apoptotic activated caspase-3. He-
matoxylin counterstained. 4 μm-thick, magnification bar=50 μm.
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weights, adipose cell size, and blood concentra-
tions of glucose, insulin and lipids. This finding con-
trasts with our previous report, in which rats fed
sucrose for eight weeks showed increased inci-
dences of visceral fat accumulation, hyperglyce-
mia, hyperinsulinemia and hyperlipidemia relative
to those fed palatinose (12). We attribute the differ-
ences between 4-wk and 8-wk feeding results to
time-dependent responses to carbohydrate loading.
Previous reports are consistent with this hypothe-
sis, in that feeding rats sucrose for a long term
(15 wk or 20 wk) increased plasma glucose and in-
sulin levels, body weight, and adipose tissue mass
and cell size (21, 22), whereas sucrose feeding for
a short term (3 wk or 4 wk) resulted in no signifi-
cant changes.
Differences in dietary fatty acid profile have been
reported to influence the fatty acid composition of
adipose tissue and membrane phospholipids, as
well as membrane protein function (23-26). Die-
tary linoleic acid has been reported to increase li-
noleic acid levels in rat adipose cell membrane
phospholipids (23, 25, 26). Linoleic acid incorpo-
rated in phospholipids is known to be converted to
arachidonic acid, an important precursor of eicosa-
noid lipid mediators (i.e., prostaglandins, hydrop-
eroxyeicosatetraenoic acids (HPETEs), and leukot-
rienes) that play a pivotal regulatory role in inflam-
matory responses (27). In contrast, a diet rich in
oleic acid has been reported to decrease arachi-
donic acid mobilization from membrane phosphol-
ipids and to reduce the production of prostaglandin
E2 in rat macrophages (28). Similar to our results
with carbohydrate feeding for only four weeks, die-
tary effects on inflammatory status that were evi-
dent after eight weeks of feeding rats a diet rich
in linoleic acid (PL and SL) (but not oleic-acid) (12)
also were not evident in this experiment. We hy-
pothesize that changes in dietary fat that lead to
membrane composition changes and modulate adi-
pose tissue function may require a longer dura-
tion of feeding than the four-week period in this
experimental procedure.
The pancreas was the only organ in which we
observed striking morphological differences be-
tween rats in the four feeding groups : Pancreatic
tissue sections from PO rats showed small oval
islets with normal cell architecture ; PL pancreatic
sections showed small but somewhat irregular
islets with disrupted cell architecture and moder-
ate β-cell loss ; SO rat islets were enlarged and ir-
regular with almost intact cell architecture and
moderate β-cell loss ; SL rat islets were hypertrophic
and more irregular in shape, with abnormal cell
architecture and progressive β-cell loss. These re-
sults were consistent with a previous study in
which Zucker fatty rats that consumed SL and SO
diets for eight weeks developed pancreatic islet
hypertrophy, whereas those that consumed SL
and PL showed significant reduction in β-cell area
(12). These findings combined suggest that the
pancreas is the initial site where dietary carbohy-
drates and fats act together to mediate dynamic
changes in pancreatic islet formation via a mecha-
nism that is independent of glycemic control or
adiposity.
In Zucker fatty (fa/fa) rats, mutation of the leptin
receptor gene results in animals that are hyper-
phasic, obese, hyperlipidemic, hyperinsulinemic
and severely insulin-resistant, but not overtly hy-
perglycemic (29). These features make this strain
a useful model for investigating islet β-cell com-
pensation for insulin resistance. In a preliminary
study, we confirmed that our experimental diets
had no differential effects on pancreatic morphol-
ogy in metabolically normal Sprague-Dawley rats
by using the same procedure as used in the cur-
rent study. Islet hyperplasia and hypertrophy are
pathological changes in islet morphology that oc-
cur in response to obesity-associated insulin resis-
tance. In both the current and previous studies us-
ing Zucker fatty rats, we observed that islets of
sucrose-fed rats were significantly larger than those
of palatinose-fed rats. In nutrient terms, the prin-
cipal difference between sucrose and palatinose is
their digestibility.
Palatinose is a naturally occurring α-1,6 -linked
glucose and fructose disaccharide that is isocaloric
with sucrose (16.7kJ/g), but is absorbed more
slowly. Although palatinose is completely hydro-
lyzed and absorbed, the hydrolysis rate of palati-
nose in rat and human intestine averages only 11-
25 % (30), resulting in suppression of postpran-
dial/fasted hyperglycemia and hyperinsulinemia
relative to sucrose (4, 10, 11). Although the mecha-
nistic details are unclear, the preventing effect of
palatinose or aggravating effect of sucrose on islet
hypertrophy may be due to the opposing effects of
these sugars on glycemia and insulinotropy. In the
current study, no differences in fasted glucose and
insulin levels were noted between rats fed palati-
nose and sucrose for four weeks. Nevertheless,
postprandial glucose and insulin levels, which were
not measured, might have differed as reported
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previously by our group (10, 11). Other investiga-
tors have also reported that sucrose and other high
glycemic starch amylopectin can induce islet hy-
pertrophy (31-33). Furthermore, amylopectin-fed
rats had larger and more fibrotic islets than low
glycemic-amylose-fed rats without decrease in in-
sulin sensitivity (32).
Peripheral insulin sensitivity is a major deter-
minant for islet morphology (34). Recently, he-
patic fatty acid composition regulated by a long-
chain fatty acid elongase, Elovl6, was reported as
an independent determinant for obesity-induced
insulin resistance (35). Although we did not meas-
ure hepatic fatty acid composition of the Zucker
fatty rats that consumed our experimental diets,
the hepatic expression levels of Elovl6 were simi-
lar among groups (data not shown). However, the
careful assessments of pelipheral insulin sensitiv-
ity and tissue fatty acid composition will be needed
to elucidate the dietary regulation of islet morphol-
ogy in our experimental procedure.
Development of type 2 diabetes is associated with
progressive histophathological changes in pan-
creatic islets, including selective loss of β-cells
and fibrosis (36). The most obvious mechanism to
explain pancreatic decompensation is a progres-
sive loss of β-cell mass, which is hastened by is-
let fibrosis. Our data demonstrate that palatinose,
relative to sucrose, had an antifibrotic effect on the
islets of Zucker fatty rats : Sucrose-fed rats showed
a much higher proportion of distinctly fibrotic is-
lets than palatinose-fed rats, and SL islets exhib-
ited more pronounced fibrosis than SO rats.
Our data agree with other studies demonstrating
that feeding normal and diabetic rats sucrose and
high-glycemic amylopectin led to islet fibrosis ac-
companied with islet hypertrophy (19, 32). In ad-
dition, in vitro studies showed that high concen-
tration of glucose (which can result from sucrose
feeding) induced pancreatic stellate cell (PSC) pro-
liferation, resulting in increased extracellular ma-
trix production and a consequent aggravation of
fibrosis (37, 38). High glucose and high insulin
have been reported to have an additive effect on
the activation and proliferation of rat PSCs (39).
The extensive fibrosis seen in SL rats may be due
to a combination of dietary sucrose and linoleic
acid inducing postprandial hyperglycemia and
hyperinsulinemia simultaneously in response to
linoleic acid potentiation of glucose-induced insu-
lin secretion via the leukocyte type 12-lipoxygenase
(12-LOX) pathway (40, 41).
Apoptosis is another major contributor to β-cell
loss. Our structural studies clearly illustrated is-
lets with pronounced apoptosis, as well as abnor-
mal α-cell distribution, in linoleic-acid-fed rats
relative to oleic-acid-fed rats. Because the special-
ized architecture and relative distribution of cell
types within islets are likely to play important
roles in islet function and survival, loss of cell-to-
cell communication in disrupted islets may also
promote apoptosis (42).
Glucolipotoxicity theory proposes that simulta-
neous increases in blood glucose and lipids result
in an intracellular accumulations of lipid metabo-
lites, which have highly deleterious effects on cell
function and accelerate β-cell apoptosis (43). This
theory links several dietary factors, including types
of fat especially, closely to the development of β-
cell apoptosis. β-cell apoptosis has been shown to
be induced by saturated fatty acids (SFA ; palmitic
acid, stearic acid) whereas unsaturated fatty acids
(MUFAs, PUFAs) have no or little effects (9, 44-
46). Eitel, et al. have reported that oleic and lino-
leic acids prevented SFA-induced β-cell apoptosis
identically (44), and also that linoleic acid had no
effect on caspase-3 activity (45). The basis for this
inconsistency with our results may involve the 12-
LOX pathway : Leukocyte type 12-LOX, which is
expressed specifically in pancreatic β-cells, cata-
lyzes the conversion of arachidonic acid and lino-
leic acid to the cytotoxic compounds 12-hydroper-
oxyeicostetraenic acid (12-HPETE) and 13-hydrop-
eroxyoctadecadienoic acid (13-HPODE), respec-
tively (47-49). Thus, dietary feeding with linoleic
acid could promote an increase in the abundance
of arachidonic-acid- and linoleic-acid-containing
phospholipids in islets (26, 41), stimulating 12-
LOX-induced formation of pro-apoptotic agents.
Further studies will be needed to investigate the
modulation of 12-LOX in pancreatic β-cells under
these dietary conditions.
We hypothesize that an advancement of fibrosis
coupled with an increase in apoptosis contribute
to the striking β-cell loss seen in the islets of SL
rats, and that an absence of both states may help
preserve of β-cells in PO rats. Findings from obese
Zucker rats fed for four versus eight weeks pro-
vide strong evidence that pancreatic islets may be
target sites that translate the effects of different
combinations of dietary carbohydrates and fats
into metabolic changes. Our findings indicate that
sucrose and linoleic acid together may act to in-
duce subtle but striking changes in pancreatic is-
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lets long before manifestation of type 2 diabetes
symptoms. A combination of palatinose and oleic
acid, which would help prevent deleterious changes
in pancreatic islets, may provide a new dietary ap-
proach toward blocking links between obesity to
type 2 diabetes.
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